Skip to content

Next-gen Fenestrated Endgraft to seek indication Expansion for arch aneurysm treatment

Next-gen Fenestrated Endgraft to seek indication Expansion for arch aneurysm treatment - TEVAR using Next-gen Fenestrated Endgraft

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007213
Enrollment
120
Registered
2012-02-02
Start date
2011-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic aortic aneurysm with unsuitable anatomy for endovascular repair using current stent-grafts

Interventions

All patients are undergone TEVAR(Thoracic Endovascular Aneurysm Repair) for thoracic aortic aneurysm.Tokyo Women&#39
s Medical University provide homemade stent graft to every institutes.

Sponsors

Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients are identified as those with at least one of the following: 1,An thoracic aortic aneurysm more than 50 mm wide. 2,The aneurysm has enlarged by more than 5 mm in less than 12 months. 3,Saccular aneurysm larger than normal 10mm in maximum transverse diameter

Exclusion criteria

Exclusion criteria: 1,Less than 20 years old 2,Pregnant females 3,Estimated life expectancy of less than twelve months. 4,Never indicate thier intention 5,With NYHA class IV 6,Recent (within three (3) months) myocardial infarction. 7,Recent (within three months) Cerebral Vascular Accident (CVA). 8,Connective tissue disease (e.g., Marfans and Ehlers-Danlos syndrome). 9,History of bleeding diathesis(including high DIC score, more than 6, caused by aneurysm without palliative therapy) coagulopathy, or refuses blood transfusions. 10,Sensitivities or allergies to stainless steel, ePTFE, PVDF, contrast media, heparin. 11,With unclear cerebellar arteries circle of Willis ,who need to be blocked their subclavian artery with stent graft without bilateral suclavian artery bypass beforehand. 12,Never plan to be blocked their left subclavian artery with less than 10mm proximal landing zone from left subclavialn artery to aneurysm . 13,Never plan to be blocked their left carotid artery with less than 10mm proximal landing zone from left carotid artery to aneurysm. 14,Never plan to be blocked their brachiocephalic trunk with less than 10mm proximal landing zone from brachiocephalic trunk to aneurysm. 15,Plan to be blocked their celiac trunk with unclear connection from SMA to celiac trunk via pancreaticoduodenal arcade. 16,Plan to be blocked their celiac trunk with less than 15mm proximal landing zone from SMA to aneurysm. 17,Never plan to be blocked their celiac trunk with less than 15mm proximal landing zone from celiac trunk to aneurysm. 18,Unfavorable access route with calcification, stenosis and tortuous iliac. 19,Unfavorable landing zone with calcification, mural hematoma and athero. 20,Significant formation of atheroma in access route and are concerned with risk of atherothrombosis. 21,Thoracic aneurysm with a contained rupture. 22,With less than 18mm and more than 43mm aortic diameter in proximal landing zone. 23,With active systemic infections

Design outcomes

Primary

MeasureTime frame
Aneurysm related event-free survival rate at one year

Secondary

MeasureTime frame
Evaluation of the efficacy and safety such as primary success rate and rate of major complication

Countries

Japan

Contacts

Public ContactTakashi Azuma

Tokyo Women's Medical University Cardiovascularsurgery

azumaro-ham@umin.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026